AMIpharm Co., Ltd.
Quick facts
Phase 3 pipeline
- Matching placebo of AYP-101
This is a matching placebo control and contains no active pharmaceutical ingredient.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: